Strong Recommendation Grade A Corollary Recommendation In the general population aged 60 years or older, if pharmacologic treatment for high BP results in lower achieved SBP (for example, <140 mm Hg) and treatment is not associated with adverse effects on health or quality of life, treatment does not need to be adjusted. Expert Opinion Grade E Recommendation 1 is based on evidence statements 1 through 3 from question 2 in which there is moderate- to high-quality evi- dence from RCTs that in the general population aged 60 years or older, treating high BP to a goal of lower than 150/90 mm Hg re- ducesstroke,heartfailure,andcoronaryheartdisease(CHD).There tion 2 that setting a goal SBP of lower than 140 mm Hg in this age group provides no additional benefit compared with a higher goal SBP of 140 to 160 mm Hg or 140 to 149 mm Hg.9,10 thatmettheeligibilitycriteriaandthateithercomparedtreatmentwith a particular goal vs no treatment or placebo or compared treatment with one BP goal with treatment to another BP goal. The trials on whichtheseevidencestatementsandthisrecommendationarebased Strengths,limitations,andotherconsiderationsrelatedtothisevidence reviewarepresentedintheevidencestatementnarrativesandclearly support the benefit of treating to a BP lower than 150 mm Hg. treated hypertensive patients aged 60 years or older in whom SBP vious guideline recommendations.12 The panel s opinion is that in these patients, it is not necessary to adjust medication to allow BP Table 3. Strength of Recommendation Grade Strength of Recommendation A Strong Recommendation There is high certainty based on evidence that the net benefita is substantial. B Moderate Recommendation There is moderate certainty based on evidence that the net benefit is moderate to substantial or there is high certainty that the net benefit is moderate. C Weak Recommendation There is at least moderate certainty based on evidence that there is a small net benefit. 